Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,692 | -52,892 | -195,795 | -159,148 | -97,718 |
| Depreciation Amortization | 1,459 | 2,184 | 2,229 | 1,062 | 346 |
| Accounts payable and accrued liabilities | 1,445 | 347 | -307 | 2,049 | 1,846 |
| Other Working Capital | -192,759 | -9,497 | -7,105 | -277 | -3,880 |
| Other Operating Activity | 61,855 | 27,339 | 47,982 | 38,138 | 19,615 |
| Operating Cash Flow | $-83,308 | $-32,519 | $-152,996 | $-118,176 | $-79,791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,340 | -31 | -5,813 | -4,951 | -3,666 |
| Purchase Of Investment | -16,184 | -14,433 | -219,427 | -183,056 | -117,027 |
| Sale Of Investment | 101,122 | 57,200 | 289,398 | 234,168 | 153,868 |
| Investing Cash Flow | $87,278 | $42,736 | $64,158 | $46,161 | $33,175 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17 | 5 | 2,460 | 2,040 | 839 |
| Other Financing Activity | 0 | 0 | -72 | -72 | -72 |
| Financing Cash Flow | $17 | $5 | $2,388 | $1,968 | $767 |
| Beginning Cash Position | 26,662 | 26,662 | 113,112 | 113,112 | 113,112 |
| End Cash Position | 30,649 | 36,884 | 26,662 | 43,065 | 67,263 |
| Net Cash Flow | $3,987 | $10,222 | $-86,450 | $-70,047 | $-45,849 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,308 | -32,519 | -152,996 | -118,176 | -79,791 |
| Capital Expenditure | -32 | -31 | -5,852 | -4,990 | -3,698 |
| Free Cash Flow | -83,340 | -32,550 | -158,848 | -123,166 | -83,489 |